
Ovarian stimulation for in vitro fertilization in patients with endometriosis
Author(s) -
Zikopoulos Kostantinos,
Kolibianakis Efstratios M.,
Devroey Paul
Publication year - 2004
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1111/j.0001-6349.2004.00543.x
Subject(s) - endometriosis , medicine , in vitro fertilisation , stimulation , gonadotropin releasing hormone , pregnancy , human fertilization , hormone , gynecology , andrology , endocrinology , luteinizing hormone , biology , genetics , anatomy
The use of gonadotropin‐releasing hormone (GnRH) agonists in a long protocol appears to enhance the probability of conception in the presence of endometriosis. In addition, there is evidence to suggest that the use of prolonged downregulation with GnRH agonists prior to ovarian stimulation for in vitro fertilization (IVF) is beneficial for achieving pregnancy. Until now, GnRH antagonists have not been used in patients with endometriosis. The management of endometriomas prior to stimulation for IVF and its impact on reproductive outcome are still subject to debate.